Antibacterial drugs prescribed for dogs and cats in Sweden and Norway 1990-1998

• Published in: Acta veterinaria scandinavica 2001-01, Vol.42 (1), p.189-198, Article 189
• Main Authors: Odensvik, K, Grave, K, Greko, C
• Format: Article
• Language: English
• Subjects: Animals; Anti-Infective Agents - therapeutic use; Antibacterial agents; antibacterials; antibiotics; antimicrobial; Beta lactam antibiotics; Beta lactamases; Cat Diseases - drug therapy; Cats; Dog Diseases - drug therapy; Dogs; Drug Prescriptions - statistics & numerical data; Drug Prescriptions - veterinary; Drug resistance; drug statistics; Drug Utilization - statistics & numerical data; Norway; Original; Pharmaceutical industry; prescription data; Sulfonamides; Sweden; Wholesale industry; wholesalers' statistics
• ISSN: 0044-605X; 1751-0147; 1751-0147
• DOI: 10.1186/1751-0147-42-189

The usage of veterinary antibacterial drugs in dogs and cats in Sweden and Norway for the period 1990-1998 was investigated by use of drug wholesalers' statistics. Additionally, usage of human antibacterial drugs in these species in Sweden was investigated by use of prescription data for the period 1996-1998. On average, more than 50% of the prescribed veterinary antibacterials in Sweden were beta-lactam antibiotics. In Norway, about 75% of the preparations prescribed for dogs and cats contained sulfonamides and trimethoprim. Furthermore, the prescription data from Sweden showed a reduced usage of human antibacterials prescribed for dogs and cats since the beginning of the 1980s. Approximately 20% of the prescribed packages for dogs in the years 1996-1998 were human approved drugs. The corresponding figure for cats was 13%. The differences between the countries in the choice of antibacterial drugs can be explained by differences in the availability of approved preparations during the study period. The consumption of veterinary antibacterials in dogs and cats in Sweden during the period was in the range of 3% to 8% of the total use of veterinary antibacterials. The corresponding figures in Norway were in the range of 3% to 7%. It is of vital importance to study usage patterns of antibacterial drugs in dogs and cats in surveillance and control of bacterial resistance, but also in discussions of therapeutic appropriateness. Therefore, further research is needed in this area.